2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

被引：326
作者：
Lloyd-Jones, Donald M. [1 ,2 ,3 ]
Morris, Pamela B. [4 ]
Ballantyne, Christie M. [5 ,6 ,7 ,8 ]
Birtcher, Kim K. [9 ]
Daly, David D., Jr. [10 ]
DePalma, Sondra M. [11 ,12 ]
Minissian, Margo B. [13 ]
Orringer, Carl E. [14 ]
Smith, Sidney C., Jr. [15 ,16 ]
机构：
[1] Northwestern Univ, Dept Prevent Med, Evanston, IL 60208 USA
[2] Northwestern Univ, Clin & Translat Sci Inst, Clin & Translat Res, Evanston, IL 60208 USA
[3] Northwestern Univ, Clin & Translat Sci Inst, Evanston, IL 60208 USA
[4] Med Univ S Carolina, Div Cardiol, Med, Charleston, SC USA
[5] Baylor Coll Med, Houston, TX 77030 USA
[6] Methodist Debakey Heart & Vasc Ctr, Med, Houston, TX USA
[7] Methodist Debakey Heart & Vasc Ctr, Genet, Charleston, SC USA
[8] Methodist Debakey Heart & Vasc Ctr, Cardiovasc Res Sect, Charleston, SC USA
[9] Univ Houston, Coll Pharm, Houston, TX 77004 USA
[10] Med Univ S Carolina, Charleston, SC USA
[11] Penn State Hlth Milton S Hershey Med Ctr, Inst Heart & Vasc, Adv Practice, Hershey, PA USA
[12] Penn State Hlth Milton S Hershey Med Ctr, Inst Heart & Vasc, Hershey, PA USA
[13] Cedars Sinai Heart Inst, Barbara Streisand Womens Heart Ctr, Los Angeles, CA USA
[14] Univ Miami, Miller Sch Med, Med, Coral Gables, FL 33124 USA
[15] Univ N Carolina, Ctr Cardiovasc Sci & Med, Med, Chapel Hill, NC 27515 USA
[16] Univ N Carolina, Ctr Cardiovasc Sci & Med, Chapel Hill, NC 27515 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 01期
关键词：
ACC Expert Consensus Decision Pathway; ASCVD; bile acid sequestrants; cholesterol; dyslipidemia; ezetimibe; LDL-C; lipids; PCSK9; inhibitors; statins; HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; LIPID ASSOCIATION RECOMMENDATIONS; PATIENT-CENTERED MANAGEMENT; SCIENTIFIC STATEMENT; REDUCING LIPIDS; HEART-FAILURE; DOUBLE-BLIND; TASK-FORCE; ROSUVASTATIN; DYSLIPIDEMIA;
D O I：
10.1016/j.jacc.2016.03.519
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：92 / 125
页数：34
相关论文
共 40 条
  • [21] Rosuvastatin in older patients with systolic heart failure
    Kjekshus, John
    Apetrei, Eduard
    Barrios, Vivencio
    Boehm, Michael
    Cleland, John G. F.
    Cornel, Jan H.
    Dunselman, Peter
    Fonseca, Candida
    Goudev, Assen
    Grande, Peer
    Gullestad, Lars
    Hjalmarson, Ake
    Hradec, Jaromir
    Janosi, Andras
    Kamensky, Gabriel
    Komajda, Michel
    Korewicki, Jerzy
    Kuusi, Timo
    Mach, Francois
    Mareev, Vyacheslav
    McMurray, John J. V.
    Ranjith, Naresh
    Schaufelberger, Maria
    Vanhaecke, Johan
    van Veldhuisen, Dirk J.
    Waagstein, Finn
    Wedel, Hans
    Wikstrand, John
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22) : 2248 - 2261
  • [22] Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
    Landray, Martin J.
    Haynes, Richard
    Hopewell, Jemma C.
    Parish, Sarah
    Aung, Theingi
    Tomson, Joseph
    Wallendszus, Karl
    Craig, Martin
    Jiang, Lixin
    Collins, Rory
    Armitage, Jane
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (03) : 203 - 212
  • [23] Intensive lipid lowering with atorvastatin in patients with stable coronary disease
    LaRosa, JC
    Grundy, SM
    Waters, DD
    Shear, C
    Barter, P
    Fruchart, J
    Gotto, AM
    Greten, H
    Kastelein, JJP
    Shepherd, J
    Wenger, NK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) : 1425 - 1435
  • [24] Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications
    Martin, Seth S.
    Blaha, Michael J.
    Elshazly, Mohamed B.
    Brinton, Eliot A.
    Toth, Peter P.
    McEvoy, John W.
    Joshi, Parag H.
    Kulkarni, Krishnaji R.
    Mize, Patrick D.
    Kwiterovich, Peter O.
    DeFilippis, Andrew P.
    Blumenthal, Roger S.
    Jones, Steven R.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (08) : 732 - 739
  • [25] Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association
    Miller, Michael
    Stone, Neil J.
    Ballantyne, Christie
    Bittner, Vera
    Criqui, Michael H.
    Ginsberg, Henry N.
    Goldberg, Anne Carol
    Howard, William James
    Jacobson, Marc S.
    Kris-Etherton, Penny M.
    Lennie, Terry A.
    Levi, Moshe
    Mazzone, Theodore
    Pennathur, Subramanian
    [J]. CIRCULATION, 2011, 123 (20) : 2292 - 2333
  • [26] Comparison of LDL Cholesterol Concentrations by Friedewald Calculation and Direct Measurement in Relation to Cardiovascular Events in 27 331 Women
    Mora, Samia
    Rifai, Nader
    Buring, Julie E.
    Ridker, Paul M.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (05) : 888 - 894
  • [27] Par Pharmaceutical Companies Inc, 2013, QUESTR CHOL PRESCR I
  • [28] Pharmacia and Upjohn Co. Division of Pfizer Inc, 2016, COL PRESCR INF
  • [29] Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
    Raal, Frederick J.
    Honarpour, Narimon
    Blom, Dirk J.
    Hovingh, G. Kees
    Xu, Feng
    Scott, Rob
    Wasserman, Scott M.
    Stein, Evan A.
    Investigators, T. E. S. L. A.
    [J]. LANCET, 2015, 385 (9965) : 341 - 350
  • [30] Lomitapide and Mipomersen Two First-in-Class Drugs for Reducing Low-Density Lipoprotein Cholesterol in Patients With Homozygous Familial Hypercholesterolemia
    Rader, Daniel J.
    Kastelein, John J. P.
    [J]. CIRCULATION, 2014, 129 (09) : 1022 - 1032
1234